S Tognella

485 total citations
37 papers, 398 citations indexed

About

S Tognella is a scholar working on Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S Tognella has authored 37 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S Tognella's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lung Cancer Treatments and Mutations (5 papers). S Tognella is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lung Cancer Treatments and Mutations (5 papers). S Tognella collaborates with scholars based in Italy, United States and United Kingdom. S Tognella's co-authors include Del Giacco Gs, Fernando C. Giuliani, Gabriella Pezzoni, R. Ceserani, Silvano Spinelli, Paolo Emilio Manconi, F. Zunino, Graziella Pratesi, Paola Perego and C. Manzotti and has published in prestigious journals such as The Lancet, Blood and Journal of Medicinal Chemistry.

In The Last Decade

S Tognella

35 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Tognella Italy 10 154 125 100 83 47 37 398
William J. Pegg United States 11 144 0.9× 293 2.3× 145 1.4× 38 0.5× 16 0.3× 13 536
Vincent H. Bono United States 12 105 0.7× 207 1.7× 61 0.6× 33 0.4× 29 0.6× 21 437
Krakoff Ih United States 13 198 1.3× 156 1.2× 53 0.5× 87 1.0× 47 1.0× 24 440
B Barbieri Italy 11 151 1.0× 271 2.2× 102 1.0× 15 0.2× 45 1.0× 20 604
A. M. Creighton United Kingdom 11 154 1.0× 218 1.7× 86 0.9× 29 0.3× 39 0.8× 18 502
Carol Hartke United States 11 237 1.5× 295 2.4× 86 0.9× 32 0.4× 63 1.3× 13 638
Sheila Prachand United States 9 184 1.2× 328 2.6× 45 0.5× 72 0.9× 31 0.7× 20 572
Pedro M. Politi United States 10 203 1.3× 181 1.4× 41 0.4× 40 0.5× 44 0.9× 18 466
Rosalind D. Friedman United States 9 101 0.7× 221 1.8× 75 0.8× 19 0.2× 16 0.3× 13 400
Christine Williamson United Kingdom 14 186 1.2× 210 1.7× 55 0.6× 15 0.2× 41 0.9× 24 443

Countries citing papers authored by S Tognella

Since Specialization
Citations

This map shows the geographic impact of S Tognella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Tognella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Tognella more than expected).

Fields of papers citing papers by S Tognella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Tognella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Tognella. The network helps show where S Tognella may publish in the future.

Co-authorship network of co-authors of S Tognella

This figure shows the co-authorship network connecting the top 25 collaborators of S Tognella. A scholar is included among the top collaborators of S Tognella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Tognella. S Tognella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pratesi, Graziella, Paola Perego, Donatella Polizzi, et al.. (1999). A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. British Journal of Cancer. 80(12). 1912–1919. 105 indexed citations
2.
Oggioni, N, et al.. (1996). Effects of moguisteine, a peripheral nonnarcotic antitussive agent, on airway inflammation in guinea-pigs in vivo. European Respiratory Journal. 9(3). 478–485. 7 indexed citations
3.
Bernareggi, A., A. Crema, Roberto Carlesi, et al.. (1995). Stereoselective pharmacokinetics of moguisteine metabolites in healthy subjects. European Journal of Drug Metabolism and Pharmacokinetics. 20(4). 263–270. 2 indexed citations
4.
Gandolfi, C., Roberto Di Domenico, Silvano Spinelli, et al.. (1995). N-Acyl-2-substituted-1,3-thiazolidines, a new class of non-narcotic antitussive agents: studies leading to the discovery of ethyl 2-[(2-methoxyphenoxy)methyl]-.beta.-oxothiazolidine-3-propanoate. Journal of Medicinal Chemistry. 38(3). 508–525. 16 indexed citations
5.
Bernareggi, A., Roberto Maffei Facino, M. Carini, et al.. (1995). Characterization of cisplatin-glutathione adducts by liquid chromatography-mass spectrometry evidence for their formation in vitro but not in vivo after concomitant administration of cisplatin and glutathione to rats and cancer patients. Journal of Chromatography B Biomedical Sciences and Applications. 669(2). 247–263. 32 indexed citations
6.
Borghi, Alessandro, et al.. (1994). Moguisteine: a novel peripheral non‐narcotic antitussive drug. British Journal of Pharmacology. 112(3). 795–800. 24 indexed citations
7.
Tognella, S. (1993). Nimesulide. Drugs. 46(Supplement 1). 275–276. 8 indexed citations
8.
Tognella, S. (1990). Pharmacological interventions to reduce platinum-induced toxicity. Cancer Treatment Reviews. 17(2-3). 139–142. 24 indexed citations
9.
Tedeschi, Michèle, Silvia Böhm, Francesco Di Re, et al.. (1990). Glutathione and detoxification. Cancer Treatment Reviews. 17(2-3). 203–208. 27 indexed citations
10.
Borghi, Alessandro, et al.. (1988). BBR 2173, a new non narcotic antitussive agent. Pharmacological Research Communications. 20. 171–171. 5 indexed citations
11.
Mantovani, Giovanna, et al.. (1983). Effect of conalbumin on phytomitogen stimulation and E-rosette formation of human peripheral lymphocytes in normal subjects.. PubMed. 5(1). 107–11. 2 indexed citations
12.
Mantovani, Giovanna, et al.. (1982). Acute erythroblastic leukemia (di guglielmo's disease) as a terminating event in a very-long survivor (27 years) with Hodgkin's disease.. PubMed. 67(3). 411–7. 3 indexed citations
13.
Tognella, S, et al.. (1978). [Immunologic aspects of Hodgkin's disease].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 69(37). 2511–7. 1 indexed citations
14.
Tognella, S, et al.. (1975). Effects of Hodgkin Cytotoxic Serum on Electrophoretic Mobility of Normal and Hodgkin Peripheral Blood Lymphocytes.. Tumori Journal. 61(1). 45–52. 6 indexed citations
15.
Gs, Del Giacco, et al.. (1975). LYMPHOCYTES IN SPLEEN IN HODGKIN'S DISEASE. The Lancet. 305(7902). 332–333. 10 indexed citations
16.
Tognella, S, et al.. (1975). Effects of Hodgkin Cytotoxic Serum on Blast Transformation of Normal and Hodgkin Human Peripheral Blood Lymphocytes.. Tumori Journal. 61(1). 53–62. 4 indexed citations
17.
Tognella, S, et al.. (1974). Macrophage Electrophoretic Migration Test for Lymphocyte Sensitization to Tumor Antigens.. Tumori Journal. 60(3). 203–210. 3 indexed citations
18.
Gs, Del Giacco, et al.. (1974). [Immunology of Hodgkin's disease. Facts and considerations].. PubMed. 56(5). 392–7. 1 indexed citations
19.
Gs, Del Giacco, et al.. (1972). [Delayed sensitivity in Hodgkin's disease].. PubMed. 57(9). 524–8. 1 indexed citations
20.
Gs, Del Giacco, et al.. (1969). Immunological reaction and Hodgkin's disease.. BMJ. 3(5667). 414.1–414. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026